...
首页> 外文期刊>Poultry Science >Effects of the commercial in ovo injection of 25-hydroxycholecalciferol on broiler posthatch performance and carcass characteristics.
【24h】

Effects of the commercial in ovo injection of 25-hydroxycholecalciferol on broiler posthatch performance and carcass characteristics.

机译:卵内注射25-羟基胆钙化固醇的商品化对肉仔鸡孵化后性能和car体特性的影响。

获取原文
获取原文并翻译 | 示例

摘要

In ovo injection of 25-hydroxycholecalciferol [25(OH)D3] has been shown to improve hatchability of injected broiler eggs. Effects of the in ovo injection of commercial diluent containing various levels of 25(OH)D3 on broiler posthatch performance and carcass characteristics were investigated in 2 trials. On each of 10 tray levels of a single-stage incubator, all treatment groups were randomly represented with each containing 21 and 40 eggs in trials 1 and 2, respectively. Treatments included noninjected and diluent-injected (100 L commercial diluent-injected) controls, and those that received 0.15, 0.30, 0.60, or 1.20 g of 25(OH)D3 in trial 1 and 0.20, 0.60, 1.80, or 5.4 g of 25(OH)D3 in trial 2, in 100 L of commercial diluent using a commercial multi-egg injector on d 18 of incubation. On d 21 of incubation, chicks from each treatment replicate group were placed in corresponding floor pens. Feed intake, BW gain, and feed conversion were determined for the weekly and cumulative 0 to 21 d age intervals in trial 1 and for the weekly and cumulative 0 to 48 d age intervals in trial 2. In trial 2, 2 birds from each sex were selected from each treatment replicate group for determination of processing carcass characteristics on d 49 posthatch. Feed intake in the 0 to 7, 7 to 14, and 14 to 21 d age intervals and BW gain in the 0 to 7 and 14 to 21 d age intervals were affected by treatment in trial 2. The in ovo injection of up to 1.20 and 0.60 g of 25(OH)D3 in trials 1 and 2, respectively, did not affect the BW gain of birds during the 0 to 7, 7 to 14, and 14 to 21 d age intervals compared with the noninjected and diluent-injected control groups. It was concluded that the in ovo injection of up to 1.20 g of 25(OH)D3 into the amnion has no detrimental effect on the overall posthatch performance of broilers.Registry Number/Name of Substance 0 (Vitamins). P6YZ13C99Q (Calcifediol).
机译:在卵内注射25-羟基胆钙化固醇[25(OH)D3]已显示可改善所注射肉鸡卵的孵化率。在2个试验中研究了卵内注射含25(OH)D3含量不同的商品稀释剂对肉仔鸡孵化后性能和car体特性的影响。在单阶段培养箱的10个托盘水平上,在试验1和2中,所有处理组均随机代表21个和40个卵。处理包括未注射和注射稀释剂的对照(100 L注射商业稀释剂的对照),以及在试验1中接受0.15、0.30、0.60或1.20 g的25(OH)D3的对照组和0.20、0.60、1.80或5.4 g的对照组。试验2中的25(OH)D3,在孵化后第18天使用商业多蛋注射器注入100 L商业稀释剂中。在孵育的第21天,将来自每个处理重复组的小鸡置于相应的地板笔中。在试验1中确定每周和累计0到21 d年龄间隔的采食量,体重增加和饲料转化率,在试验2中确定每周和0到48 d年龄间隔的累积采食量。在试验2中,每种性别的2只鸟从每个处理重复组中选出,以确定孵化后第49天的processing体加工特性。试验2影响了0至7、7至14、14至21 d年龄段的采食量和0至7和14至21 d年龄段的体重增加。在卵内注射的剂量最高为1.20与未注射和稀释剂注射相比,试验1和2中的0.60 g 25(OH)D3分别在0至7、7至14,和14至21 d年龄间隔内不影响禽的体重增加对照组。得出的结论是,向羊膜内卵内注射高达1.20 g的25(OH)D3对肉仔鸡的总体孵化后性能没有有害影响。注册号/物质0的名称(维生素)。 P6YZ13C99Q(Calcifediol)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号